Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
(2R,6R)-Hydroxynorketamine for Neuropathic Pain
NCT05864053Phase 2Recruiting
- Sponsor
- Rush University Medical Center
- Start
- Sep 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of (2R,6R)-hydroxynorketamine in neuropathic pain, sponsored by Rush University Medical Center. Started Sep 2024; status: recruiting.
02
Drugs
(2R,6R)-hydroxynorketamine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT05864053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05864053.